Permeation of topically applied caffeine through human skin - A comparison of in vivo and in vitro data

British Journal of Clinical Pharmacology

Volumn 68, Issue 2, 2009, Pages 181-186

  Trauer, Sindy ^a,b   Patzelt, Alexa ^a   Otberg, Nina ^a   Knorr, Fanny ^a   Rozycki, Christel ^b   Balizs, Gabor ^b   Büttemeyer, Rolf ^a   Linscheid, Michael ^c   Liebsch, Manfred ^b   Lademann, Jürgen ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Caffeine; Follicular penetration; Hair follicle

Indexed keywords

CAFFEINE;

ADULT; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DIFFUSION; DRUG ABSORPTION; EXPERIMENT; FEMALE; HAIR FOLLICLE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; KINETICS; METABOLISM; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN PERMEABILITY;

ADMINISTRATION, CUTANEOUS; ADULT; CAFFEINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HAIR FOLLICLE; HUMANS; MIDDLE AGED; MODELS, BIOLOGICAL; PERMEABILITY; SKIN ABSORPTION;

EID: 68449101181     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2009.03463.x     Document Type: Article

References (25)

1. Bouwstra J, Pilgram G, Gooris G, Koerten H, Ponec M. New aspects of the skin barrier organization. Skin Pharmacol Appl Skin Physiol 2001 14 (Suppl. 1 52 62.
2. Choi EH, Lee SH, Ahn SK, Hwang SM. The pretreatment effect of chemical skin penetration enhancers in transdermal drug delivery using iontophoresis. Skin Pharmacol Appl Skin Physiol 1999 12 : 326 35.
3. Elias PM. Epidermal lipids, barrier function, and desquamation. J Invest Dermatol 80 (Suppl 1983 44s 49s.
4. Elias PM. Stratum corneum defensive functions: an integrated view. J Invest Dermatol 2005 125 : 183 200.
5. Hadgraft J. Modulation of the barrier function of the skin. Skin Pharmacol Appl Skin Physiol 2001 14 (Suppl. 1 72 81.
6. Moser K, Kriwet K, Naik A, Kalia YN, Guy RH. Passive skin penetration enhancement and its quantification in vitro. Eur J Pharm Biopharm 2001 52 : 103 12.
7. Schaefer H, Redelmeier T. Skin barrier: Principles of percutaneous absorption. Basel : Karger, 1996 56.
8. Agarwal R, Katare OP, Vyas SP. The pilosebaceous unit: a pivotal route for topical drug delivery. Methods Find Exp Clin Pharmacol 2000 22 : 129 33.
9. Barry BW. Drug delivery routes in skin: a novel approach. Adv Drug Deliv Rev 2002 54 (Suppl. 1 S31 40.
10. Genina EA, Bashkatov AN, Sinichkin YP, Kochubey VI, Lakodina NA, Altshuler GB, Tuchin VV. In vitro and in vivo study of dye diffusion into the human skin and hair follicles. J Biomed Opt 7 : 2002 471 7.
11. Lademann J, Knorr F, Richter H, Blume-Peytavi U, Vogt A, Antoniou C, Sterry W, Patzelt A. Hair follicles - an efficient storage and penetration pathway for topically applied substances. Skin Pharmacol Physiol 2008 21 : 150 5.
12. Lauer AC, Ramachandran C, Lieb LM, Niemiec S, Weiner ND. Targeted delivery to the pilosebaceous unit via liposomes. Adv Drug Deliv Rev 1996 18 : 311 24.
13. Ogiso T, Shiraki T, Okajima K, Tanino T, Iwaki M, Wada T. Transfollicular drug delivery: Penetration of drugs through human scalp skin and comparison of penetration between scalp and abdominal skins in vitro. J Drug Target 2002 10 : 369 78.
14. Otberg N, Patzelt A, Rasulev U, Hagemeister T, Linscheid M, Sinkgraven R, Sterry W, Lademann J. The role of hair follicles in the percutaneous absorption of caffeine. Br J Clin Pharmacol 2008 65 : 488 92.
15. Teichmann A, Jacobi U, Ossadnik M, Richter H, Koch S, Sterry W, Lademann J. Differential stripping: determination of the amount of topically applied substances penetrated into the hair follicles. J Invest Dermatol 2005 125 : 264 9.
16. Teichmann A, Otberg N, Jacobi U, Sterry W, Lademann J. Follicular penetration: development of a method to block the follicles selectively against the penetration of topically applied substances. Skin Pharmacol Physiol 2006 19 : 216 23.
17. Trauer S, Patzelt A, Knorr F, Richter H, Liebsch M, Rozycki C, Balizs G, Buettemeyer R, Linscheid M, Franz TJ, Lademann J. Development of an in vitro modified skin absorption test for the investigation of the follicular penetration pathway of caffeine. Skin Pharm Physiol 2009 (in press).
18. OECD. OECD (Organisation for Economic Co-operation and Development) Guidelines for Testing Chemicals-428 Skin absorption: In vitro method. OECD TG 428 2004.
19. Akomeah FK, Martin GP, Brown MB. Variability in human skin permeability in vitro: comparing penetrants with different physicochemical properties. J Pharm Sci 2007 96 : 824 34.
20. Maibach HI, Feldman RJ, Milby TH, Serat WF. Regional variation in percutaneous penetration in man. Pesticides Arch Environ Health 1971 23 : 208 11.
21. Scheuplein RJ. Mechanism of percutaneous absorption. II. Transient diffusion and the relative importance of various routes of skin penetration. J Invest Dermatol 1967 48 : 79 88.
22. Patzelt A, Knorr F, Blume-Peytavi U, Sterry W, Lademann J. Hair follicles, their disorders and their opportunities. Drug Discovery Today 2008 5 : 173 81.
23. Li L, Hoffman RM. The feasibility of targeted selective gene therapy of the hair follicle. Nature Med 1995 1 : 705 6.
24. Zesch A, Schaefer H, Stuttgen G. The quantitative distribution of percutaneously applied caffeine in the human skin. Arch Dermatol Res 1979 266 : 277 83.
25. Patzelt A, Richter H, Buettemeyer R, Huber HJ, Blume-Peytavi U, Sterry W, Lademann J. Differential stripping demonstrates a significant reduction of the hair follicle reservoir in vitro compared to in vivo. Eur J Pharm Biopharm 2008 70 : 234 8.